Foveal Thickness Fluctuations in Anti-VEGF Treatment for Central Retinal Vein Occlusion

Purpose: The aim of this study was to examine the effects of foveal thickness (FT) fluctuation (FTF) on 2-year visual and morphological outcomes of eyes with central retinal vein occlusion (CRVO) undergoing anti-VEGF treatment for recurrent macular edema (ME) based on a pro re nata regimen. Design:...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Daisuke Nagasato, MD, PhD, Yuki Muraoka, MD, PhD, Mao Tanabe, MD, Naomi Nishigori, MD, Rie Osaka, MD, Yoshinori Mitamura, MD, PhD, Hitoshi Tabuchi, MD, PhD, Tomoaki Murakami, MD, PhD, Sotaro Ooto, MD, Kiyoshi Suzuma, MD, PhD, Akitaka Tsujikawa, MD, PhD
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2024-03-01
Rangatū:	Ophthalmology Science
Ngā marau:	Central retinal vein occlusion Fluctuation anti-VEGF
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2666914523001501
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Foveal Thickness Fluctuations in Anti-VEGF Treatment for Central Retinal Vein Occlusion

Ngā tūemi rite